TNFSF10 and Familial prostate cancer: Although a number of prostate cancer cells exhibited high resistance to TRAIL effect [71], 50–200 nM triptolide significantly sensitized LNCaP and PC-3M prostate cancer cells to TRAIL-mediated cellular apoptosis by upregulating the expression of death receptor 5 and inhibiting prostate cancer development [72].